Viewing data from:

ASHLYNA

ANDA

ETHINYL ESTRADIOL; LEVONORGESTREL | A203163 | GLENMARK PHARMACEUTICALS LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: QUARTETTE(TE code: AB)

Medicare Part D Spending

CMS annual spending data for Ashlyna (2023)

Total Spending

$87K

Total Claims

1,105

Beneficiaries

463

Avg Cost/Unit

$0.86

Spending Trend

$313K(2019)→$267K(2020)→$117K(2021)→$101K(2022)→$87K(2023)

YoY Change:-17.2%

5yr CAGR:-12.4%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.03MG,0.01MG;0.15MG,N/A

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Feb 23, 2015

No patent or exclusivity listings for this strength.